Taieb A, Alomar A, Bhm M, DellAnna ML, De Pase A, Eleftheriadou V, et al
However, modern research Read More Protecting Muscle While Treating Obesity: New Protein Targets for Older Adults on GLP-1s Jun 16, 2026 Articles, Diet and Nutrition, Exercise, Geriatric Medicine, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity, Obesity 1,740 views The rise of highly effective GLP-1 receptor agonists and dual incretin therapies has transformed obesity treatment
Semaglutide: In clinical trials, patients lost an average of 15% of their body weight over 68 weeks
For people tracking their semaglutide dosage , these effects typically strengthen as the dose increases through the titration schedule